Actively Recruiting

Age: 18Years +
All Genders
NCT06374342

Bone Substitutes Outcomes - Post Market Follow-up

Led by Teknimed · Updated on 2025-09-09

425

Participants Needed

6

Research Sites

576 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A Post-Market Clinical Follow-Up (PMCF) Study to collect clinical data on safety and performance of all TEKNIMED Bone Substitute range of products: CERAFORM, TRIHA+, NANOGEL, and all their private labels. TEKNIMED bone substitutes are legacy products, some marketed for more than 20 years. Their performance and safety have already been demonstrated by Post-Market Surveillance and previous clinical studies. The current Post-Market Clinical Follow-Up study aims to confirm these claims by collecting data in a "real-life" setting. The study is a retrospective and prospective global, single arm, non-controlled, multicentric, prospective observational study. Patients will be followed as per local standard medical care of the sites.

CONDITIONS

Official Title

Bone Substitutes Outcomes - Post Market Follow-up

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be 18 years or older
  • Willing to sign informed consent approved by IRB or EC or not opposed to use of clinical data (France)
  • For prospective inclusion: scheduled for surgery needing TEKNIMED bone substitute use as per instructions
  • For retrospective inclusion: had surgery with TEKNIMED bone substitute between January 1, 2015 and site initiation visit, informed of study and not opposed to data use or willing to sign consent at first follow-up
Not Eligible

You will not qualify if you...

  • Under trusteeship or guardianship
  • Pregnant or breastfeeding women
  • Procedures other than those stated in the indications section
  • Allergic to product components
  • For CERAFORM and TRIHA+: treatment of large bone defects without mechanical stabilization system
  • For NANOGEL: use in vertebroplasty procedures
  • For NANOGEL: subcutaneous use

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Pôle Rachis Hôpital Privé d'Eure et Loir

Mainvilliers, Eure et Loir, France, 28300

Actively Recruiting

2

Hôpital Joseph Ducuing

Toulouse, Haute Garonne, France, 31000

Actively Recruiting

3

Clinique Médipole Garonne

Toulouse, Haute Garonne, France, 31100

Actively Recruiting

4

CHRU Brabois

Nancy, Meurthe et Moselle, France, 54000

Actively Recruiting

5

Clinique du Pré

Le Mans, Sarthe, France, 72000

Actively Recruiting

6

OCM Klinik GmbH

München, Bavaria, Germany, D-81369

Actively Recruiting

Loading map...

Research Team

S

Solange VAN DE MOORTELE, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

8

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here